Early Commercial Launch Demonstrates Strong Physician Demand, Successful Pre-Authorisations, and Widespread Payor Coverage...
The company completed a human factors validation study at Johns Hopkins Hospital...
Designed for Freedom, the newly FDA-cleared system will be showcased at RSNA...
The newly issued patent strengthens Nexalin’s expanding intellectual property estate, supporting the Company’s DIFS platform and ongoing clinical and regulatory initiatives...
Philips’ ambulatory and diagnostic solutions and services are now available to 3.4 million Optum policyholders for enhanced outpatient cardiac monitoring...
The unified brand is now ASPEN...
The investment includes facility expansions, new manufacturing processes, advanced quality control systems, and implementation of new production technologies...
Greenwood brings extensive leadership experience across a range of healthcare services...
The voluntary action affects devices manufactured before May 12, 2025, after reports of component detachment linked to patient injuries and one death, with Olympus reinforcing safeguards to prioritise patient safety....
The bone-sparing implant, cleared for both anatomic and reverse shoulder arthroplasty, enhances surgical flexibility and patient outcomes while reinforcing the company’s leadership in shoulder care innovation....
